fda approved semaglutide approves obesity drug that helped people cut weight 15% What's New in Obesity Treatment?

The most common side effects of Ozempic, according to manufacturer Novo Nordisk, include gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, and constipation

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications widely used for type 2 diabetes and obesity

Semaglutide and tirzepatide are both effective medications for helping people lose weight

Open communication with your healthcare provider about GLP-1 medication use is essential for safe and effective treatment

These patients had maintained stable stimulator settings that effectively managed clinically manifested motor symptoms for approximately 3 months before their enrollment in the study